• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539524
INE600L01024
147.3423418
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LALPATHLAB
59.54
33679.7
EPS(TTM)
Face Value()
Div & Yield %
33.7
10
1.02
 

epl ltd
IRFC signs Rs 13,527 cr term loan agreement with L&T Metro Rail (Hyderabad)
May 25,2026
Indian Railway Finance Corporation signed a Rs 13,527 crore term loan agreement with L&T Metro Rail (Hyderabad) (L&TMRHL) to refinance the debt obligations of the Hyderabad Metro Rail project, marking a landmark refinancing transaction in India's urban transit sector.

The refinancing follows the transfer of 100 per cent ownership of L&TMRHL from Larsen & Toubro to the Government of Telangana through Hyderabad Metro Rail (HMRL), transforming the metro network into a strategic public mobility asset under state ownership and creating a stronger financial foundation for the phased expansion of Hyderabad's metro ecosystem.

The facility will refinance existing debt obligations, including non-convertible debentures (NCDs), commercial papers and term loans, enabling an orderly exit for existing lenders while significantly improving the project's long-term financial sustainability.